Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Efficiency of IgM Anti-Cardiolipin Serum Level Screening for Monitoring Response to Anti-Tuberculosis Treatment in Comparison with Sputum Smear Conversion Test

Hamidreza Kouhpayeh 1 , Abbass-Ali Niazi 2 , * and Reza Karimian 3
Authors Information
1 Infectious Diseases Department, Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran
2 Pathology Department, Zahedan University of Medical Sciences, Zahedan, Iran
3 Infectious Diseases Department, Zahedan University of Medical Sciences, Zahedan, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: March 2018, 20 (3); e57134
  • Published Online: February 28, 2018
  • Article Type: Research Article
  • Received: June 28, 2017
  • Revised: October 28, 2017
  • Accepted: February 20, 2018
  • DOI: 10.5812/zjrms.57134

To Cite: Kouhpayeh H, Niazi A, Karimian R. Efficiency of IgM Anti-Cardiolipin Serum Level Screening for Monitoring Response to Anti-Tuberculosis Treatment in Comparison with Sputum Smear Conversion Test, Zahedan J Res Med Sci. 2018 ; 20(3):e57134. doi: 10.5812/zjrms.57134.

Copyright © 2018, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Longo D, Fauci AS, Kasper D, Hauser SL. Harrison's principles of internal medicine. 19th ed. New York: Mc Graw-Hill; 2015.
  • 2. Ministry of Health & Medical Education . Center for Disease Control. TB situation in Iran; 2016. Available from:
  • 3. World Health Organization . Global tuberculosis report. 2016. Available from:
  • 4. Coban AY, Cihan CC, Bilgin K, Uzun M, Akgunes A, Cetinkaya E, et al. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs. Int J Tuberc Lung Dis. 2006;10(4):450-3. [PubMed: 16602412].
  • 5. World Health Organization . . Treatment of tuberculosis: Guidelines for treatment of drug-susceptible tuberculosis and patient care. fourth ed. Geneve, Switzerland: WHO Press; 2017.
  • 6. Talati NJ, Seybold U, Humphrey B, Aina A, Tapia J, Weinfurter P, et al. Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis. 2009;9:15. doi: 10.1186/1471-2334-9-15. [PubMed: 19208218].
  • 7. Brennan PJ, Nikaido H. The envelope of mycobacteria. Annu Rev Biochem. 1995;64:29-63. doi: 10.1146/ [PubMed: 7574484].
  • 8. Jacobsen M, Mattow J, Repsilber D, Kaufmann SH. Novel strategies to identify biomarkers in tuberculosis. Biol Chem. 2008;389(5):487-95. doi: 10.1515/BC.2008.053. [PubMed: 18953715].
  • 9. Hardy RR. B-1 B cell development. J Immunol. 2006;177(5):2749-54. doi: 10.4049/jimmunol.177.5.2749. [PubMed: 16920907].
  • 10. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011;11(1):34-46. doi: 10.1038/nri2901. [PubMed: 21151033].
  • 11. Converse PJ, Dannenberg AJ, Estep JE, Sugisaki K, Abe Y, Schofield BH, et al. Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect Immun. 1996;64(11):4776-87. [PubMed: 8890239].
  • 12. Dannenberg AJ. Liquefaction and cavity formation in pulmonary TB: a simple method in rabbit skin to test inhibitors. Tuberculosis (Edinb). 2009;89(4):243-7. doi: 10.1016/ [PubMed: 19559651].
  • 13. Goodridge A, Cueva C, Lahiff M, Muzanye G, Johnson JL, Nahid P, et al. Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response. Tuberculosis (Edinb). 2012;92(3):243-7. doi: 10.1016/ [PubMed: 22406155].
  • 14. Kumaresan JA, Ahsan Ali AK, Parkkali LM. Tuberculosis control in Bangladesh: success of the DOTS strategy. Int J Tuberc Lung Dis. 1998;2(12):992-8. [PubMed: 9869115].
  • 15. Nowak D, Radenbach D, Magnussen H. [Chemotherapy of pulmonary tuberculosis. Sputum culture conversion in 8 weeks in 84% of patients]. Dtsch Med Wochenschr. 1987;112(36):1367-70. doi: 10.1055/s-2008-1068252. [PubMed: 3622281].
  • 16. Rieder HL. Sputum smear conversion during directly observed treatment for tuberculosis. Tuber Lung Dis. 1996;77(2):124-9. doi: 10.1016/S0962-8479(96)90026-X. [PubMed: 8762846].
  • 17. Thorson A, Long NH, Larsson LO. Chest X-ray findings in relation to gender and symptoms: a study of patients with smear positive tuberculosis in Vietnam. Scand J Infect Dis. 2007;39(1):33-7. doi: 10.1080/00365540600951176. [PubMed: 17366010].
  • 18. Goodridge A, Zhang T, Miyata T, Lu S, Riley LW. Antiphospholipid IgM antibody response in acute and chronic Mycobacterium tuberculosis mouse infection model. Clin Respir J. 2014;8(2):137-44. doi: 10.1111/crj.12049. [PubMed: 23910993].
  • 19. Ordonez C, Tarajia M, Rivera R, Sambrano D, Batista V, Chavez M, et al. Total IgM and Anti-Phosphatidylcholine IgM Antibody Secretion Continue After Clearance of Mycobacterium bovis Bacillus Calmette-Guerin Pleural Infection. Lung. 2017;195(4):517-21. doi: 10.1007/s00408-017-0019-0. [PubMed: 28551717].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments